2.30
-0.01 (-0.43%)
-0.01 (-0.43%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.01 | -0.43% | 2.30 | 16:44:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.33 | 2.245 | 2.37 | 2.30 | 2.31 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.26 | 2.31 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,773 | 868,732 | $ 2.30 | $ 1,997,812 | 3,284,338 | 1.00 - 7.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:43:27 | 10 | $ 2.26 | USD |
Hepion Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 73.66M | 32.03M | 32.02M | $ - | $ - | -15.29 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.18 | 2.39 | 2.16 | 2.30 | 1,044,422 | 0.12 | 5.5% |
| 1 Month | 2.26 | 2.74 | 1.91 | 2.24 | 2,043,446 | 0.04 | 1.77% |
| 3 Months | 3.38 | 3.4226 | 1.51 | 1.95 | 2,181,200 | -1.08 | -31.95% |
| 6 Months | 3.84 | 6.18 | 1.51 | 2.34 | 1,204,371 | -1.54 | -40.1% |
| 1 Year | 5.70 | 7.50 | 1.00 | 2.84 | 1,193,388 | -3.40 | -59.65% |
| 3 Years | 3.11 | 8.35 | 1.00 | 3.27 | 1,131,884 | -0.81 | -26.05% |
| 5 Years | 3.11 | 8.35 | 1.00 | 3.27 | 1,131,884 | -0.81 | -26.05% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. The company's cyclophilin inhibitor, CRV431 targets multiple biochemical pathways involved in the progression of liver disease. |
